SCHEMBL5458919

SCHEMBL5458919

COc1cc2c(=O)c([14C]#N)c[nH]c2cc1OCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 3/20 0.60
CTSV O60911 2/20 0.60
POLB P06746 1/20 0.51
ALDH1A1 P00352 2/20 0.49
HPGD P15428 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49
SRD5A1 P18405 1/20 0.47
SRD5A2 P31213 1/20 0.47
MDH2 P40926 1/20 0.42
ELANE P08246 1/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
CISD1 Q9NZ45 1/20 0.41
PDE4D Q08499 3/20 0.40
CTSB P07858 1/20 0.40
PDE4A P27815 2/20 0.40
PDE4B Q07343 2/20 0.40
PDE4C Q08493 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL256578 0.83 CTSL (0.64) CTSLCTSVPOLBALDH1A1HPGD
SCHEMBL2063876 0.83 CTSV (0.64) CTSLCTSVPOLBALDH1A1HPGD
SCHEMBL2063188 0.82 CTSV (0.60) CTSLCTSVPOLBALDH1A1HPGD
SCHEMBL7823652 0.79 CTSV (0.56) CTSLCTSVPOLBALDH1A1HPGD
SCHEMBL187798 0.79 CTSV (0.56) CTSLCTSVPOLBALDH1A1HPGD
SCHEMBL248836 0.79 CTSV (0.59) CTSLCTSVPOLBALDH1A1HPGD
SCHEMBL17067000 0.79 CTSV (0.58) CTSLCTSVPOLBALDH1A1HPGD
SCHEMBL18474478 0.78 CTSV (0.57) CTSLCTSVPOLBALDH1A1HPGD
SCHEMBL15730198 0.78 CTSV (0.57) CTSLCTSVPOLBALDH1A1HPGD
SCHEMBL18975225 0.78 SRD5A1 (0.60) CTSLCTSVPOLBALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070208164-A1 Methods of synthesizing radiolabeled 3-cyano[14C]quinolines WYETH (US) 2007-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070208164-A1 Methods of synthesizing radiolabeled 3-cyano[14C]quinolines QPCT, RECQL, CBR3 CTSL 1286/4885CTSV 621/4885POLB 655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.